Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activins and activin antagonists in hepatocellular carcinoma

1 Jan 2008

Abstract excerpt

In many parts of the world hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality but the underlying molecular pathology is still insufficiently understood. There is increasing evidence that activins, which are members of the transforming growth factor beta (TGFbeta) superfamily of growth and differentiation factors, could play important roles in liver carcinogenesis. Activins are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kruppel-like factors research
Share to Pancreatic and Hepatic Oncology Research
Share to TGF-β signaling in diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18350601
DOI: 10.3748/wjg.14.1699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activins and activin antagonists in hepatocellular carcinomaPMID 18350601Read ↗

Activin receptors in human cancer: Functions, mechanisms, and potential clinical applicationsSemantic proximity Read ↗

Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 ReceptorsSemantic proximity Read ↗

Activin signaling as an emerging target for therapeutic interventionsSemantic proximity Read ↗

Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by ActivinSemantic proximity Read ↗

Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.Semantic proximity Read ↗

Potential Roles of BMP9 in Liver FibrosisSemantic proximity Read ↗

Activins, Myostatin and Related TGF-β Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune DisordersSemantic proximity Read ↗

BMPR2 inhibits activin and BMP signaling via wild-type ALK2Semantic proximity Read ↗

Activin A is a prominent autocrine regulator of hepatocyte growth arrestSemantic proximity Read ↗

Control of Hepatic Differentiation by Activin/TGF&beta; SignalingSemantic proximity Read ↗

BMPR2 inhibits activin- and BMP-signaling via wild type ALK2Semantic proximity Read ↗

Different Immunoregulation Roles of Activin A Compared With TGF-βSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.